Ina Ly

1.1k total citations
28 papers, 421 citations indexed

About

Ina Ly is a scholar working on Neurology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ina Ly has authored 28 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 13 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ina Ly's work include Neurofibromatosis and Schwannoma Cases (13 papers), Glioma Diagnosis and Treatment (12 papers) and Meningioma and schwannoma management (7 papers). Ina Ly is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (13 papers), Glioma Diagnosis and Treatment (12 papers) and Meningioma and schwannoma management (7 papers). Ina Ly collaborates with scholars based in United States, France and United Kingdom. Ina Ly's co-authors include Jaishri O. Blakeley, Patrick Y. Wen, Elizabeth R. Gerstner, Jörg Dietrich, Tracy T. Batchelor, Ovidiu C. Andronesi, Bruce R. Rosen, S. Andrew, Isabel Arrillaga‐Romany and A. John Iafrate and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ina Ly

25 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ina Ly United States 9 178 171 79 77 70 28 421
Melanie Barz Germany 14 79 0.4× 232 1.4× 104 1.3× 79 1.0× 128 1.8× 40 468
Sussan J. Salas United States 12 81 0.5× 117 0.7× 61 0.8× 97 1.3× 59 0.8× 22 328
Cynthia T. Welsh United States 11 92 0.5× 93 0.5× 116 1.5× 153 2.0× 108 1.5× 33 537
Ryo Nosaka Japan 11 73 0.4× 179 1.0× 88 1.1× 83 1.1× 88 1.3× 24 343
John David Tesoro-Tess Italy 10 162 0.9× 122 0.7× 79 1.0× 63 0.8× 51 0.7× 16 399
Yukitomo Ishi Japan 11 85 0.5× 129 0.8× 43 0.5× 52 0.7× 52 0.7× 55 316
Nicolai El Hindy Germany 18 243 1.4× 201 1.2× 134 1.7× 129 1.7× 104 1.5× 42 792
Yukito Maeda Japan 12 137 0.8× 150 0.9× 259 3.3× 91 1.2× 101 1.4× 45 508
Saya Ozaki Japan 11 90 0.5× 110 0.6× 44 0.6× 56 0.7× 50 0.7× 47 321
Mohamed S Abdelbaki United States 12 113 0.6× 191 1.1× 27 0.3× 83 1.1× 57 0.8× 64 528

Countries citing papers authored by Ina Ly

Since Specialization
Citations

This map shows the geographic impact of Ina Ly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Ly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Ly more than expected).

Fields of papers citing papers by Ina Ly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Ly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Ly. The network helps show where Ina Ly may publish in the future.

Co-authorship network of co-authors of Ina Ly

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Ly. A scholar is included among the top collaborators of Ina Ly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Ly. Ina Ly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metser, Ur, Aruz Mesci, Rosanna Chan, et al.. (2025). [18F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry. Journal of Nuclear Medicine. 66(4). 537–542.
2.
Blakeley, Jaishri O., Ina Ly, Yemima Berman, et al.. (2023). Current and Emerging Imaging Techniques for Neurofibromatosis Type 1–Associated Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1397–1405. 6 indexed citations
3.
Rhodes, Steven D., Frank McCormick, Ross Cagan, et al.. (2023). RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights. Journal of Investigative Dermatology. 143(8). 1358–1368. 2 indexed citations
4.
Ly, Ina, Carlos G. Romo, Kristen M. Kelly, et al.. (2023). Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1388–1396. 6 indexed citations
5.
Staedtke, Verena, Piotr Topilko, Lu Q. Le, et al.. (2023). Existing and Developing Preclinical Models for Neurofibromatosis Type 1−Related Cutaneous Neurofibromas. Journal of Investigative Dermatology. 143(8). 1378–1387. 5 indexed citations
6.
Sakamoto, Fernanda H., Scott R. Plotkin, Ina Ly, et al.. (2023). Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods. Journal of the American Academy of Dermatology. 90(4). 767–774. 2 indexed citations
7.
Niendorf, Kristin B., et al.. (2022). Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis. American Journal of Medical Genetics Part A. 188(8). 2413–2420. 3 indexed citations
8.
Merker, Vanessa L., Justin T. Jordan, Ina Ly, et al.. (2022). Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain. Contemporary Clinical Trials. 121. 106900–106900. 3 indexed citations
9.
Ahlawat, Shivani, Ina Ly, Laura M. Fayad, et al.. (2021). Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1. Neurology. 97(7_Supplement_1). S111–S119. 8 indexed citations
10.
Merker, Vanessa L., Ina Ly, Justin T. Jordan, et al.. (2021). Validating Techniques for Measurement of Cutaneous Neurofibromas. Neurology. 97(7_Supplement_1). S32–S41. 7 indexed citations
11.
Ly, Ina, Patrick Y. Wen, & Raymond Y. Huang. (2019). Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification. Neurologic Clinics. 38(1). 95–113. 21 indexed citations
12.
Ly, Ina & Jaishri O. Blakeley. (2019). The Diagnosis and Management of Neurofibromatosis Type 1. Medical Clinics of North America. 103(6). 1035–1054. 117 indexed citations
13.
Andronesi, Ovidiu C., Isabel Arrillaga‐Romany, Ina Ly, et al.. (2018). Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nature Communications. 9(1). 1474–1474. 99 indexed citations
14.
Ly, Ina & Elizabeth R. Gerstner. (2018). The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies. Current Treatment Options in Oncology. 19(8). 40–40. 8 indexed citations
15.
Ly, Ina, Kyrre E. Emblem, Yangming Ou, et al.. (2018). Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Scientific Reports. 8(1). 17062–17062. 9 indexed citations
16.
Dietrich, Jörg, Ninib Baryawno, Naema Nayyar, et al.. (2017). Bone marrow drives central nervous system regeneration after radiation injury. Journal of Clinical Investigation. 128(1). 281–293. 37 indexed citations
17.
Ly, Ina & Patrick Y. Wen. (2017). Clinical Relevance of Steroid Use in Neuro-Oncology. Current Neurology and Neuroscience Reports. 17(1). 5–5. 28 indexed citations
18.
Ly, Ina, et al.. (2016). Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience. Oncology Letters. 11(5). 3471–3476. 16 indexed citations
19.
Ly, Ina, Steven R. Hamilton, Robert Rostomily, Jason K. Rockhill, & Maciej M. Mrugała. (2015). Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab. Journal of Neuro-Ophthalmology. 35(4). 382–386. 8 indexed citations
20.
Ly, Ina, Florian J. Fintelmann, Reza Forghani, et al.. (2011). Novel Diagnostic Approaches in Bing-Neel Syndrome. Clinical Lymphoma Myeloma & Leukemia. 11(1). 180–183. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Barz Breakdown of academic impact, for papers by Sussan J. Salas Breakdown of academic impact, for papers by Cynthia T. Welsh Breakdown of academic impact, for papers by Ryo Nosaka Breakdown of academic impact, for papers by John David Tesoro-Tess Breakdown of academic impact, for papers by Yukitomo Ishi Breakdown of academic impact, for papers by Nicolai El Hindy Breakdown of academic impact, for papers by Yukito Maeda Breakdown of academic impact, for papers by Saya Ozaki Breakdown of academic impact, for papers by Mohamed S Abdelbaki
Rankless by CCL
2026